Form 4: EG director Laura J. Hay receives 954 restricted common shares
Rhea-AI Filing Summary
Laura J. Hay, a director of Everest Group, Ltd. (EG), was granted 954 Restricted Common Shares under the company’s 2003 Non-Employee Director Equity Plan on 08/20/2025. The Form 4 shows the shares were acquired as a non-derivative award at a reported transaction price of $341.435 per share and that Ms. Hay beneficially owns 954 shares following the transaction. The filing indicates the ownership is direct and identifies the grant as restricted common shares; no exercise or conversion terms are reported because this is a non-derivative award. The document is a routine insider reporting of equity granted to a director and does not include additional financial results, plan terms beyond the plan name, or other company disclosures.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director received a routine restricted-share award of 954 shares; transaction is small relative to company-level metrics and is informational.
The Form 4 reports a non-derivative grant to Director Laura J. Hay under the 2003 Non-Employee Director Equity Plan for 954 Restricted Common Shares at a reported price of $341.435 on 08/20/2025, with 954 shares beneficially owned following the grant. This type of filing primarily notifies investors of insider holdings and aligns director compensation with shareholder outcomes. The filing lacks broader context such as total outstanding shares, aggregate director holdings across the board, or the grant’s grant-date fair value schedule, limiting assessment of dilution or materiality to shareholders.
TL;DR: Standard governance disclosure showing equity-based director compensation; no red flags in the filing itself.
The disclosure names the issuer, reporting person, relationship (Director), transaction date (08/20/2025) and identifies the award as Restricted Common Shares under the company’s 2003 Non-Employee Director Equity Plan. The report is signed and dated per Form 4 requirements. Absent additional details—such as vesting schedule, acceleration provisions, or aggregate director compensation—this remains a routine compliance disclosure reflecting alignment of director pay with equity incentives.